Mesalazine Therapy in Patients With Irritable Bowel Syndrome

• Status: Completed
• Trial end date: 2012-07-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to determine whether Mesalazine is effective in the treatment of the abdominal discomfort or pain of Irritable Bowel Syndrome patients.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: SOFAR S.p.A.
• Treatments: Mesalamine

Criteria

Inclusion Criteria:

• IBS patients with positive diagnosis inclosing Rome III criteria

Exclusion Criteria:

• Any organic or metabolic disease